BioCentury
ARTICLE | Financial News

Probiodrug amends IPO

October 13, 2014 7:00 AM UTC

Probiodrug AG, Halle/Saale, Germany Business: Neurology, Autoimmune, Inflammation Date announced: 2014-10-10 Type: IPO To be raised: Up to EUR28 million ($35.1 million) Shares: 1.5 million Price: EUR1...